Loading organizations...
SDIC Fund, officially SDIC Innovation Investment Management Co., Ltd., is a professional private equity investment manager. It specializes in value discovery and creation, deploying capital and tailored services to portfolio companies in strategic emerging industries. Focus areas include intelligent manufacturing, new energy vehicles, life sciences, ICT, AI, integrated circuits.
Established in 2009 by State Development & Investment Corporation (SDIC Group), SDIC Fund strategically deploys capital for national industrial upgrading and technological advancement. This initiative implemented professional, market-oriented investment management, fostering critical industries and innovation across the Chinese economy.
The firm attracts diverse investors, including financial institutions and social security funds, by delivering robust financial returns. SDIC Fund’s vision is to foster sustainable value creation for enterprises via long-term partnerships, advancing China's high-tech and strategic industries, contributing to national economic transformation.
Key people at SDIC Fund.
SDIC Fund has 4 tracked investments across 4 companies. The latest tracked deal is $120.0M Series C in EpimAb Biotherapeutics in March 2021.
| Date | Company | Round | Lead Investor(s) | Co-Investor(s) |
|---|---|---|---|---|
| Mar 1, 2021 | EpimAb Biotherapeutics | $120.0M Series C | Tony Rong, Sungwon Song | Cventures, Adrian Cheng, Cormorant Asset Management, Decheng Capital, Hidragon Capital, Hony Capital, Octagon Capital, ShangBay Capital, Sherpa Healthcare Partners, Yanchuang Capital |
| Oct 24, 2017 | Ninebot | $100.0M Series C | — | China Mobile |
| Aug 28, 2017 | CF PharmTech | $65.0M Series D | Sdic Fund | — |
| Nov 29, 2016 | Innovent Biologics | $260.0M Series D | Sdic Fund | Hillhouse Capital, Legend Capital, Milestone, Ping AN, Taikang, Temasek |
Key people at SDIC Fund.
